Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan-cancer analysis
- PMID: 38426625
- PMCID: PMC10905679
- DOI: 10.1002/cam4.7014
Reclassified the phenotypes of cancer types and construct a nomogram for predicting bone metastasis risk: A pan-cancer analysis
Abstract
Background: Numerous of models have been developed to predict the bone metastasis (BM) risk; however, due to the variety of cancer types, it is difficult for clinicians to use these models efficiently. We aimed to perform the pan-cancer analysis to create the cancer classification system for BM, and construct the nomogram for predicting the BM risk.
Methods: Cancer patients diagnosed between 2010 and 2018 in the Surveillance, Epidemiology, and End Results (SEER) database were included. Unsupervised hierarchical clustering analysis was performed to create the BM prevalence-based cancer classification system (BM-CCS). Multivariable logistic regression was applied to investigate the possible associated factors for BM and construct a nomogram for BM risk prediction. The patients diagnosed between 2017 and 2018 were selected for validating the performance of the BM-CCS and the nomogram, respectively.
Results: A total of 50 cancer types with 2,438,680 patients were included in the construction model. Unsupervised hierarchical clustering analysis classified the 50 cancer types into three main phenotypes, namely, categories A, B, and C. The pooled BM prevalence in category A (17.7%; 95% CI: 17.5%-17.8%) was significantly higher than that in category B (5.0%; 95% CI: 4.5%-5.6%), and category C (1.2%; 95% CI: 1.1%-1.4%) (p < 0.001). Advanced age, male gender, race, poorly differentiated grade, higher T, N stage, and brain, lung, liver metastasis were significantly associated with BM risk, but the results were not consistent across all cancers. Based on these factors and BM-CCS, we constructed a nomogram for predicting the BM risk. The nomogram showed good calibration and discrimination ability (AUC in validation cohort = 88%,95% CI: 87.4%-88.5%; AUC in construction cohort = 86.9%,95% CI: 86.8%-87.1%). The decision curve analysis also demonstrated the clinical usefulness.
Conclusion: The classification system and prediction nomogram may guide the cancer management and individualized BM screening, thus allocating the medical resources to cancer patients. Moreover, it may also have important implications for studying the etiology of BM.
Keywords: associated factors; bone metastasis; cancer classification system; prediction nomogram.
© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
All authors have no conflict of interest to disclose.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10905679/bin/CAM4-13-e7014-g004.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10905679/bin/CAM4-13-e7014-g005.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10905679/bin/CAM4-13-e7014-g003.gif)
![FIGURE 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10905679/bin/CAM4-13-e7014-g001.gif)
![FIGURE 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10905679/bin/CAM4-13-e7014-g002.gif)
Similar articles
-
Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.BMC Cancer. 2020 Nov 25;20(1):1145. doi: 10.1186/s12885-020-07635-1. BMC Cancer. 2020. PMID: 33238981 Free PMC article.
-
Novel nomogram to predict risk of bone metastasis in newly diagnosed thyroid carcinoma: a population-based study.BMC Cancer. 2020 Nov 3;20(1):1055. doi: 10.1186/s12885-020-07554-1. BMC Cancer. 2020. PMID: 33143688 Free PMC article.
-
Risk factors and nomogram for newly diagnosis of bone metastasis in bladder cancer: A SEER-based study.Medicine (Baltimore). 2020 Oct 16;99(42):e22675. doi: 10.1097/MD.0000000000022675. Medicine (Baltimore). 2020. PMID: 33080711 Free PMC article.
-
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.BMC Cancer. 2020 Jun 1;20(1):494. doi: 10.1186/s12885-020-06995-y. BMC Cancer. 2020. PMID: 32487048 Free PMC article.
-
Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.BMC Cancer. 2019 Mar 15;19(1):238. doi: 10.1186/s12885-019-5445-3. BMC Cancer. 2019. PMID: 30876473 Free PMC article.
References
-
- Schulman KL, Kohles J. Economic burden of metastatic bone disease in the U.S. Cancer. 2007;109(11):2334‐2342. - PubMed
MeSH terms
Grants and funding
- YJ2021112/the Fundamental Research Funds for the Central Universities
- 81702161/the Natural Science Foundation of China
- 81801781/the Natural Science Foundation of China
- 81802508/the Natural Science Foundation of China
- 81903398/the Natural Science Foundation of China
- 8191101553/the Natural Science Foundation of China
- 17JCQNJC11000/the Natural Science Foundation of Tianjin Science
- cstc2019jcyjmsxmX0466/Chongqing Natural Science Foundation Program
- 2023SCUH0026/"From 0 to 1" innovation project of Sichuan University
- 2023ZYD0097/Sichuan Provincial Science and Technology Department central guide local science and technology development special project
- 2023NSFSC1927/Sichuan Outstanding Youth Science Fund Project
- Q21016/Sichuan Medical Association Youth Innovation project
- GSSCU2023043/2023 Sichuan University graduate education teaching reform project
- 2021YFS0101/The Foundation of Science and Technology of Sichuan Province
LinkOut - more resources
Full Text Sources
Medical